COMPANY
ASAKE Biotechnology, LLC
ASAKE Biotechnology is developing technologies in the identification and production of potential therapeutic metabolites from silenced genes in natural living organisms (plants and microbials) as well as in the construction of living medicines, including both supplements and prescription medicines. ASAKE Biotechnology, LLC researches and develops health therapeutics utilizing natural resources. From company website Source · Oct 13, 2026
Timeline
- Grant Government grant — STTR: $625,501 (annual award, as published), announced Jul 17, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗
Funding
- Government grant — STTR: $625,501 (annual award, as published), announced Jul 17, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗
NIH awards 3
- NIH award 5R42DK131839-03 FY2024: $740,897 awarded for that fiscal year; activity R42 (STTR); PI WU, SHIYONG; recipient as written: ASAKE BIOTECHNOLOGY, LLC, ATHENS, OH. A dual-acting small molecule for the treatment source ↗
- NIH award 2R42DK131839-02A1 FY2023: $609,183 awarded for that fiscal year; activity R42 (STTR); PI WU, SHIYONG; recipient as written: ASAKE BIOTECHNOLOGY, LLC, ATHENS, OH. A dual-acting small molecule for the treatme source ↗
- NIH award 1R41DK131839-01 FY2021: $299,974 awarded for that fiscal year; activity R41 (STTR); PI BAHAMONDES LORCA, VERONICA ANDREA; recipient as written: ASAKE BIOTECHNOLOGY, LLC, ATHENS, OH. A dual-acting small mole source ↗